|
1
|
Martelotto LG, Ng CK, Piscuoglio S,
Weigelt B and Reis-Filho JS: Breast cancer intra-tumor
heterogeneity. Breast Cancer Res. 16:2102014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dontu G, Liu S and Wicha MS: Stem cells in
mammary development and carcinogenesis: Implications for prevention
and treatment. Stem Cell Rev. 1:207–213. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fillmore C and Kuperwasser C: Human breast
cancer stem cell markers CD44 and CD24: Enriching for cells with
functional properties in mice or in man? Breast Cancer Res.
9:3032007. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sheridan C, Kishimoto H, Fuchs RK,
Mehrotra S, Bhat-Nakshatri P, Turner CH, Goulet R Jr, Badve S and
Nakshatri H: CD44+/CD24- breast cancer cells exhibit enhanced
invasive properties: An early step necessary for metastasis. Breast
Cancer Res. 8:R592006. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wright MH, Calcagno AM, Salcido CD,
Carlson MD, Ambudkar SV and Varticovski L: Brca1 breast tumors
contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell
characteristics. Breast Cancer Res. 10:R102008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Weiswald LB, Bellet D and Dangles-Marie V:
Spherical cancer models in tumor biology. Neoplasia. 17:1–15. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Serrano M: The INK4a/ARF locus in murine
tumorigenesis. Carcinogenesis. 21:865–869. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Dontu G, Abdallah WM, Foley JM, Jackson
KW, Clarke MF, Kawamura MJ and Wicha MS: In vitro propagation and
transcriptional profiling of human mammary stem/progenitor cells.
Genes Dev. 17:1253–1270. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Scheel C, Eaton EN, Li SH, Chaffer CL,
Reinhardt F, Kah KJ, Bell G, Guo W, Rubin J, Richardson AL and
Weinberg RA: Paracrine and autocrine signals induce and maintain
mesenchymal and stem cell states in the breast. Cell. 145:926–940.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dey D, Saxena M, Paranjape AN, Krishnan V,
Giraddi R, Kumar MV, Mukherjee G and Rangarajan A: Phenotypic and
functional characterization of human mammary stem/progenitor cells
in long term culture. PLoS One. 4:e53292009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cicalese A, Bonizzi G, Pasi CE, Faretta M,
Ronzoni S, Giulini B, Brisken C, Minucci S, Di Fiore PP and Pelicci
PG: The tumor suppressor p53 regulates polarity of self-renewing
divisions in mammary stem cells. Cell. 138:1083–1095. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Manuel Iglesias J, Beloqui I,
Garcia-Garcia F, Leis O, Vazquez-Martin A, Eguiara A, Cufi S, Pavon
A, Menendez JA, Dopazo J and Martin AG: Mammosphere formation in
breast carcinoma cell lines depends upon expression of E-cadherin.
PLoS One. 8:e772812013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lei B, Zhang XY, Zhou JP, Mu GN, Li YW,
Zhang YX and Pang D: Transcriptome sequencing of HER2-positive
breast cancer stem cells identifies potential prognostic marker.
Tumour Biol. 37:14757–14764. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lo PK and Chen H: Cancer stem cells and
cells of origin in MMTV-Her2/neu-induced mammary tumorigenesis.
Oncogene. 32:1338–1340. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Alexander PB, Chen R, Gong C, Yuan L,
Jasper JS, Ding Y, Markowitz GJ, Yang P, Xu X, McDonnell DP, et al:
Distinct receptor tyrosine kinase subsets mediate anti-HER2 drug
resistance in breast cancer. J Biol Chem. 292:748–759. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ma H, Lu Y, Malone KE, Marchbanks PA,
Deapen DM, Spirtas R, Burkman RT, Strom BL, McDonald JA, Folger SG,
et al: Mortality risk of black women and white women with invasive
breast cancer by hormone receptors, HER2, and p53 status. BMC
Cancer. 13:2252013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Blume-Jensen P and Hunter T: Oncogenic
kinase signalling. Nature. 411:355–365. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Harari D and Yarden Y: Molecular
mechanisms underlying ErbB2/HER2 action in breast cancer. Oncogene.
19:6102–6114. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang KH, Kao AP, Chang CC, Lee JN, Hou MF,
Long CY, Chen HS and Tsai EM: Increasing CD44+/CD24(−) tumor stem
cells and upregulation of COX-2 and HDAC6, as major functions of
HER2 in breast tumorigenesis. Mol Cancer. 9:2882010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Korkaya H, Paulson A, Iovino F and Wicha
MS: HER2 regulates the mammary stem/progenitor cell population
driving tumorigenesis and invasion. Oncogene. 27:6120–6130. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pickl M and Ries CH: Comparison of 3D and
2D tumor models reveals enhanced HER2 activation in 3D associated
with an increased response to trastuzumab. Oncogene. 28:461–468.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Oak PS, Kopp F, Thakur C, Ellwart JW, Rapp
UR, Ullrich A, Wagner E, Knyazev P and Roidl A: Combinatorial
treatment of mammospheres with trastuzumab and salinomycin
efficiently targets HER2-positive cancer cells and cancer stem
cells. Int J Cancer. 131:2808–2819. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yarden Y: Biology of HER2 and its
importance in breast cancer. Oncology. 61 Suppl 2:S1–S13. 2001.
View Article : Google Scholar
|
|
24
|
Belsches-Jablonski AP, Biscardi JS, Peavy
DR, Tice DA, Romney DA and Parsons SJ: Src family kinases and HER2
interactions in human breast cancer cell growth and survival.
Oncogene. 20:1465–1475. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhang W, Ding W, Chen Y, Feng M, Ouyang Y,
Yu Y and He Z: Up-regulation of breast cancer resistance protein
plays a role in HER2-mediated chemoresistance through PI3K/Akt and
nuclear factor-kappa B signaling pathways in MCF7 breast cancer
cells. Acta Biochim Biophys Sin (Shanghai). 43:647–653. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hsieh TH, Tsai CF, Hsu CY, Kuo PL, Lee JN,
Chai CY, Hou MF, Chang CC, Long CY, Ko YC and Tsai EM: Phthalates
stimulate the epithelial to mesenchymal transition through an
HDAC6-dependent mechanism in human breast epithelial stem cells.
Toxicol Sci. 128:365–376. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang R, Lv Q, Meng W, Tan Q, Zhang S, Mo X
and Yang X: Comparison of mammosphere formation from breast cancer
cell lines and primary breast tumors. J Thorac Dis. 6:829–837.
2014.PubMed/NCBI
|
|
28
|
Ponti D, Costa A, Zaffaroni N, Pratesi G,
Petrangolini G, Coradini D, Pilotti S, Pierotti MA and Daidone MG:
Isolation and in vitro propagation of tumorigenic breast cancer
cells with stem/progenitor cell properties. Cancer Res.
65:5506–5511. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Fu YZ, Yan YY, He M, Xiao QH, Yao WF, Zhao
L, Wu HZ, Yu ZJ, Zhou MY, Lv MT, et al: Salinomycin induces
selective cytotoxicity to MCF-7 mammosphere cells through targeting
the Hedgehog signaling pathway. Oncol Rep. 35:912–922. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Patrawala L, Calhoun T,
Schneider-Broussard R, Zhou J, Claypool K and Tang DG: Side
population is enriched in tumorigenic, stem-like cancer cells,
whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic.
Cancer Res. 65:6207–6219. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hsieh TH, Tsai CF, Hsu CY, Kuo PL, Hsi E,
Suen JL, Hung CH, Lee JN, Chai CY, Wang SC and Tsai EM: n-Butyl
benzyl phthalate promotes breast cancer progression by inducing
expression of lymphoid enhancer factor 1. PLoS One. 7:e427502012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Götte M, Wolf M, Staebler A, Buchweitz O,
Kelsch R, Schüring AN and Kiesel L: Increased expression of the
adult stem cell marker Musashi-1 in endometriosis and endometrial
carcinoma. J Pathol. 215:317–329. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Michel M, Török N, Godbout MJ, Lussier M,
Gaudreau P, Royal A and Germain L: Keratin 19 as a biochemical
marker of skin stem cells in vivo and in vitro: Keratin 19
expressing cells are differentially localized in function of
anatomic sites, and their number varies with donor age and culture
stage. J Cell Sci. 109:1017–1028. 1996.PubMed/NCBI
|
|
35
|
Larouche D, Hayward C, Cuffley K and
Germain L: Keratin 19 as a stem cell marker in vivo and in vitro.
Methods Mol Biol. 289:103–110. 2005.PubMed/NCBI
|
|
36
|
Nikpour P, Mowla SJ, Forouzandeh-Moghaddam
M and Ziaee SA: The stem cell self-renewal gene, Musashi 1, is
highly expressed in tumor and non-tumor samples of human bladder.
Indian J Cancer. 50:214–218. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kawai T, Yasuchika K, Ishii T, Katayama H,
Yoshitoshi EY, Ogiso S, Kita S, Yasuda K, Fukumitsu K, Mizumoto M,
et al: Keratin 19, a cancer stem cell marker in human
hepatocellular carcinoma. Clin Cancer Res. 21:3081–3091. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
El Sakka D, Gaber MA, Abdou AG, Wahed MA,
Saleh AA and Shehata W: Stem cell markers (Cytokeratin 17 and
Cytokeratin 19) in scarring and nonscarring alopecia. J Cutan
Aesthet Surg. 9:165–171. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rajendran V and Jain MV: In vitro
tumorigenic assay: Colony forming assay for cancer stem cells.
Methods Mol Biol 1692. 89–95. 2018. View Article : Google Scholar
|
|
40
|
Vadlamudi R, Mandal M, Adam L, Steinbach
G, Mendelsohn J and Kumar R: Regulation of cyclooxygenase-2 pathway
by HER2 receptor. Oncogene. 18:305–314. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lanza-Jacoby S, Burd R, Rosato FE Jr,
McGuire K, Little J, Nougbilly N and Miller S: Effect of
simultaneous inhibition of epidermal growth factor receptor and
cyclooxygenase-2 in HER-2/neu-positive breast cancer. Clin Cancer
Res. 12:6161–6169. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Pattarozzi A, Gatti M, Barbieri F, Würth
R, Porcile C, Lunardi G, Ratto A, Favoni R, Bajetto A, Ferrari A
and Florio T: 17beta-estradiol promotes breast cancer cell
proliferation-inducing stromal cell-derived factor-1-mediated
epidermal growth factor receptor transactivation: Reversal by
gefitinib pretreatment. Mol Pharmacol. 73:191–202. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Thapa R and Wilson GD: The importance of
CD44 as a stem cell biomarker and therapeutic target in cancer.
Stem Cells Int 2016. 20872042016.
|
|
44
|
Cauley JA, Lucas FL, Kuller LH, Stone K,
Browner W and Cummings SR: Elevated serum estradiol and
testosterone concentrations are associated with a high risk for
breast cancer. Study of osteoporotic fractures research group. Ann
Intern Med. 130:270–277. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yun SP, Lee MY, Ryu JM, Song CH and Han
HJ: Role of HIF-1alpha and VEGF in human mesenchymal stem cell
proliferation by 17beta-estradiol: Involvement of PKC, PI3K/Akt,
and MAPKs. Am J Physiol Cell Physiol. 296:C317–C326. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hong L, Colpan A and Peptan IA:
Modulations of 17-beta estradiol on osteogenic and adipogenic
differentiations of human mesenchymal stem cells. Tissue Eng.
12:2747–2753. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Clarke RB, Spence K, Anderson E, Howell A,
Okano H and Potten CS: A A putative human breast stem cell
population is enriched for steroid receptor-positive cells. Dev
Biol. 277:443–456. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Ithimakin S, Day KC, Malik F, Zen Q,
Dawsey SJ, Bersano-Begey TF, Quraishi AA, Ignatoski KW, Daignault
S, Davis A, et al: HER2 drives luminal breast cancer stem cells in
the absence of HER2 amplification: Implications for efficacy of
adjuvant trastuzumab. Cancer Res. 73:1635–1646. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
North TE, Goessling W, Walkley CR,
Lengerke C, Kopani KR, Lord AM, Weber GJ, Bowman TV, Jang IH,
Grosser T, et al: Prostaglandin E2 regulates vertebrate
haematopoietic stem cell homeostasis. Nature. 447:1007–1011. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Dirix LY, Ignacio J, Nag S, Bapsy P, Gomez
H, Raghunadharao D, Paridaens R, Jones S, Falcon S, Carpentieri M,
et al: Treatment of advanced hormone-sensitive breast cancer in
postmenopausal women with exemestane alone or in combination with
celecoxib. J Clin Oncol. 26:1253–1259. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhang X, Schwarz EM, Young DA, Puzas JE,
Rosier RN and O'Keefe RJ: Cyclooxygenase-2 regulates mesenchymal
cell differentiation into the osteoblast lineage and is critically
involved in bone repair. J Clin Invest. 109:1405–1415. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Mulholland DJ, Kobayashi N, Ruscetti M,
Zhi A, Tran LM, Huang J, Gleave M and Wu H: Pten loss and RAS/MAPK
activation cooperate to promote EMT and metastasis initiated from
prostate cancer stem/progenitor cells. Cancer Res. 72:1878–1889.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Ginestier C, Hur MH, Charafe-Jauffret E,
Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG,
Liu S, et al: ALDH1 is a marker of normal and malignant human
mammary stem cells and a predictor of poor clinical outcome. Cell
Stem Cell. 1:555–567. 2007. View Article : Google Scholar : PubMed/NCBI
|
